Tony Y W Li1, Leonard Leong L Yeo2,3, Jamie Sin Ying Ho4, Aloysius S Leow1, Mark Y Chan2,5, Mayank Dalakoti5, Bernard P L Chan3, Hock Luen Teoh3, Swee-Chong Seow2,5, Pipin Kojodjojo2,5, Vijay K Sharma2,3, Benjamin Y-Q Tan6,7, Ching-Hui Sia2,4. 1. Internal Medicine Residency, National University Health System, Singapore, Singapore. 2. Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. 3. Division of Neurology, Department of Medicine, National University Health System, Singapore, Singapore. 4. Department of Medicine, University of Cambridge, Cambridge, United Kingdom. 5. Department of Cardiology, National University Heart Centre Singapore, Singapore, Singapore. 6. Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, benjamin_yq_tan@nuhs.edu.sg. 7. Division of Neurology, Department of Medicine, National University Health System, Singapore, Singapore, benjamin_yq_tan@nuhs.edu.sg.
Abstract
BACKGROUND: Several P-wave indices are thought to represent underlying atrial remodeling and have been associated with ischaemic stroke even in the absence of atrial fibrillation (AF). However, the utility of these P-wave indices in predicting outcomes in patients with embolic stroke of undetermined source (ESUS) has not been studied. The aim of this study is to examine these different P-wave indices towards predicting new-onset AF and stroke recurrence in a cohort of patients with ESUS, thereby demonstrating the value of these electrocardiographic markers for stroke risk stratification. METHODS: Between October 2014 and October 2017, consecutive patients diagnosed with ESUS were followed for new-onset AF and ischaemic stroke recurrence. The various P-wave indices, namely, the P-terminal force in the precordial lead V1 (PTFV1), P-wave duration, P-wave dispersion, interatrial blocks, and P-wave axis, were assessed on the initial electrocardiogram on presentation and studied for their relation to eventual AF detection and recurrent stroke. RESULTS: 181 ischaemic stroke patients with ESUS were recruited and followed up for a median duration of 2.1 years. An abnormal PTFV1 was associated with occult AF detection but not with recurrent ischaemic strokes. No significant association was observed between the other P-wave indices with either occult AF or stroke recurrence. CONCLUSION: PTFV1 is associated with AF detection but not recurrent strokes in ESUS patients and can be a useful electrocardiographic marker for further risk stratification in ESUS patients.
BACKGROUND: Several P-wave indices are thought to represent underlying atrial remodeling and have been associated with ischaemic stroke even in the absence of atrial fibrillation (AF). However, the utility of these P-wave indices in predicting outcomes in patients with embolic stroke of undetermined source (ESUS) has not been studied. The aim of this study is to examine these different P-wave indices towards predicting new-onset AF and stroke recurrence in a cohort of patients with ESUS, thereby demonstrating the value of these electrocardiographic markers for stroke risk stratification. METHODS: Between October 2014 and October 2017, consecutive patients diagnosed with ESUS were followed for new-onset AF and ischaemic stroke recurrence. The various P-wave indices, namely, the P-terminal force in the precordial lead V1 (PTFV1), P-wave duration, P-wave dispersion, interatrial blocks, and P-wave axis, were assessed on the initial electrocardiogram on presentation and studied for their relation to eventual AF detection and recurrent stroke. RESULTS: 181 ischaemic strokepatients with ESUS were recruited and followed up for a median duration of 2.1 years. An abnormal PTFV1 was associated with occult AF detection but not with recurrent ischaemic strokes. No significant association was observed between the other P-wave indices with either occult AF or stroke recurrence. CONCLUSION: PTFV1 is associated with AF detection but not recurrent strokes in ESUS patients and can be a useful electrocardiographic marker for further risk stratification in ESUS patients.
Authors: Marta Rubiera; Ana Aires; Kateryna Antonenko; Sabrina Lémeret; Christian H Nolte; Jukka Putaala; Renate B Schnabel; Anil M Tuladhar; David J Werring; Dena Zeraatkar; Maurizio Paciaroni Journal: Eur Stroke J Date: 2022-06-03
Authors: Slaven Pikija; Cornelia Rösler; Ursula Leitner; Thomas Zellner; Nele Bubel; Bernhard Ganser; Constantin Hecker; Johannes Sebastian Mutzenbach Journal: Front Neurol Date: 2022-01-28 Impact factor: 4.003
Authors: Jan-Thorben Sieweke; Jan Hagemus; Saskia Biber; Dominik Berliner; Gerrit M Grosse; Sven Schallhorn; Tobias Jonathan Pfeffer; Anselm A Derda; Jonas Neuser; Johann Bauersachs; Udo Bavendiek Journal: Front Cardiovasc Med Date: 2022-03-08
Authors: Fabienne Kreimer; Assem Aweimer; Andreas Pflaumbaum; Andreas Mügge; Michael Gotzmann Journal: Ann Noninvasive Electrocardiol Date: 2021-05-07 Impact factor: 1.468